Suppr超能文献

基于更新的实施研究综合框架的 HIV 暴露前预防实施的决定因素:系统评价。

Determinants of Implementation for HIV Pre-exposure Prophylaxis Based on an Updated Consolidated Framework for Implementation Research: A Systematic Review.

机构信息

Department of Psychiatry, Northwestern University Feinberg School of Medicine, Chicago, IL.

Institute for Sexual and Gender Minority Health and Wellbeing, Northwestern University, Chicago, IL.

出版信息

J Acquir Immune Defic Syndr. 2022 Jul 1;90(S1):S235-S246. doi: 10.1097/QAI.0000000000002984.

Abstract

BACKGROUND

Delivery and use of HIV pre-exposure prophylaxis (PrEP) are suboptimal in the United States. Previous reviews of barriers and facilitators have not used an implementation science lens, limiting comprehensiveness and the link to implementation strategies. To summarize the state of the science, we systematically reviewed determinants of PrEP implementation using the updated Consolidated Framework for Implementation Research (CFIR 2.0).

SETTING

PrEP-eligible communities and delivery settings in the United States.

METHODS

In January 2021, we searched Ovid MEDLINE, PsycINFO, and Web of Science for peer-reviewed articles related to HIV/AIDS, interventions, implementation, and determinants or strategies. We identified 286 primary research articles published after 1999 about US-based PrEP implementation. Team members extracted discrete "mentioned" and "measured" determinants, coding each by setting, population, valence, measurement, and CFIR 2.0 construct.

RESULTS

We identified 1776 mentioned and 1952 measured determinants from 254 to 239 articles, respectively. Two-thirds of measured determinants were of PrEP use by patients as opposed to delivery by providers. Articles contained few determinants in the inner setting or process domains (ie, related to the delivery context), even among studies of specific settings. Determinants across priority populations also focused on individual patients and providers rather than structural or logistical factors.

CONCLUSION

Our findings suggest substantial knowledge in the literature about general patient-level barriers to PrEP use and thus limited need for additional universal studies. Instead, future research should prioritize identifying determinants, especially facilitators, unique to understudied populations and focus on structural and logistical features within current and promising settings (eg, pharmacies) that support integration of PrEP into clinical practice.

摘要

背景

在美国,HIV 暴露前预防(PrEP)的提供和使用并不理想。以前关于障碍和促进因素的综述没有使用实施科学视角,限制了全面性和与实施策略的联系。为了总结科学现状,我们使用更新的实施研究综合框架(CFIR 2.0)系统地综述了 PrEP 实施的决定因素。

设定

美国有资格接受 PrEP 的社区和提供环境。

方法

2021 年 1 月,我们在 Ovid MEDLINE、PsycINFO 和 Web of Science 上搜索了与艾滋病毒/艾滋病、干预、实施以及决定因素或策略相关的同行评审文章。我们确定了 286 篇发表于 1999 年后的、关于美国 PrEP 实施的基础研究文章。团队成员从 239 篇到 254 篇文章中提取了离散的“提到”和“测量”决定因素,按设置、人群、定性、测量和 CFIR 2.0 结构对每个因素进行编码。

结果

我们从 254 篇到 239 篇文章中分别确定了 1776 个提到的和 1952 个测量的决定因素。测量的决定因素中有三分之二是患者使用 PrEP,而不是提供者提供。即使是在特定环境的研究中,文章中也很少有内部环境或过程领域的决定因素(即与提供环境相关)。优先人群的决定因素也主要关注个体患者和提供者,而不是结构性或后勤因素。

结论

我们的发现表明,文献中有大量关于一般患者使用 PrEP 的障碍的知识,因此不需要进行更多的普遍性研究。相反,未来的研究应优先确定独特的决定因素,特别是针对研究不足的人群的促进因素,并侧重于当前和有前途的环境(例如,药店)中的结构性和后勤特征,以支持将 PrEP 纳入临床实践。

相似文献

4
Factors Affecting Pre-Exposure Prophylaxis Implementation for Women in the United States: A Systematic Review.
J Womens Health (Larchmt). 2019 Sep;28(9):1272-1285. doi: 10.1089/jwh.2018.7353. Epub 2019 Jun 10.
9
Leveling Up PrEP: Implementation Strategies at System and Structural Levels to Expand PrEP Use in the United States.
Curr HIV/AIDS Rep. 2024 Apr;21(2):52-61. doi: 10.1007/s11904-024-00697-x. Epub 2024 Mar 22.

引用本文的文献

4
Implementation Determinants of PrEP and Behavioral Health Treatment Referral among HIV Test Counselors.
AIDS Behav. 2025 May;29(5):1492-1506. doi: 10.1007/s10461-025-04620-2. Epub 2025 Jan 29.
5
Determinants of Familiarity and Experience with HIV Pre-Exposure Prophylaxis in Primary Care Providers in Ontario, Canada.
J Prim Care Community Health. 2025 Jan-Dec;16:21501319251315566. doi: 10.1177/21501319251315566.
6
HIV Prevention in Syringe Service Programs Since the Start of COVID-19: Where Do We Go From Here?
Curr HIV/AIDS Rep. 2025 Jan 15;22(1):13. doi: 10.1007/s11904-024-00721-0.
7
Designing a blockchain technology platform for enhancing the pre-exposure prophylaxis care continuum.
JAMIA Open. 2024 Dec 19;7(4):ooae140. doi: 10.1093/jamiaopen/ooae140. eCollection 2024 Dec.
8
Increasing the Accessibility and Relevance of Implementation Science for Front-Line Implementers.
J Acquir Immune Defic Syndr. 2025 Apr 1;98(4):372-376. doi: 10.1097/QAI.0000000000003580. Epub 2025 Feb 19.
9
Developing a Practice-Driven Taxonomy of Implementation Strategies for HIV Prevention.
J Acquir Immune Defic Syndr. 2025 Apr 1;98(4):377-385. doi: 10.1097/QAI.0000000000003581. Epub 2025 Feb 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验